Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2013 Oct;23(8):558-67.
doi: 10.1089/cap.2012.0098.

Nutritional and safety outcomes from an open-label micronutrient intervention for pediatric bipolar spectrum disorders

Affiliations
Clinical Trial

Nutritional and safety outcomes from an open-label micronutrient intervention for pediatric bipolar spectrum disorders

Elisabeth A Frazier et al. J Child Adolesc Psychopharmacol. 2013 Oct.

Abstract

Objective: The purpose of this study was to report the safety, tolerability, and serum micronutrient concentrations and their correlations with mood changes from an 8 week pilot feasibility study of a 36 ingredient multinutrient supplement, EMPowerplus (EMP+), for pediatric bipolar spectrum disorders (BPSD).

Methods: Ten children ages 6-12 received EMP+ escalating from one to four capsules t.i.d., with four children increased to the maximum suggested dose, five capsules t.i.d. Outcome measures were micronutrient concentrations in serum and red blood cells, vital signs, body mass index (BMI), dietary intake (Food Frequency Questionnaire and 24 hour dietary recall interview), and mood and global functioning ratings.

Results: Seven children (70%) completed the study. Three (30%) terminated early for tolerability and compliance issues. Adverse effects were mild and transient, and chiefly consisted of initial insomnia or gastrointestinal (GI) upset. No differences occurred in BMI (p = 0.310) or waist-hip ratio (WHR; p = 0.674) pre- to postsupplementation. Four of the tested serum vitamin concentrations increased from pre- to postsupplementation: vitamin A-retinol, vitamin B6, vitamin E-α-tocopherol; and folate (all p<0.05). The increase in serum 25-OH vitamin D approached significance (p = 0.063). No differences were found in dietary intake pre- to postsupplementation, suggesting that blood nutrient level increases were caused by EMP+.

Conclusions: In this open prospective study, short-term use of EMP+ in children with BPSD appeared safe and well-tolerated, with a side effect profile preferable to first-line psychotropic drugs for pediatric bipolar spectrum disorders. A double-blind, randomized clinical trial is feasible, appears safe, and is warranted by open-label clinical outcomes and plausible mechanisms of action, combined with documentation of increased serum concentrations of specific micronutrients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Alpert JE. Fava M. Nutrition and depression: The role of folate. Nutr Rev. 1997;55:145. - PubMed
    1. Ambrosini PJ. Metz C. Prabucki K. Lee JC. Videotape reliability of the third revised edition of the K-SADS. J Am Acad Child Adolesc Psychiatry. 1989;28:723–728. - PubMed
    1. Text Revision. 4th ed. Washington, DC: American Psychiatric Association; 2000. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders.
    1. Arpadi SM. McMahon D. Abrams EJ. Bamji M. Purswani M. Engelson ES. Horlick M. Shane E. Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents. Pediatrics. 2009;123:121–126. - PMC - PubMed
    1. Axelson D. Birmaher BJ. Brent D. Wassick S. Hoover C. Bridge J. Ryan N. A preliminary study of the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children Mania Rating Scale for Children and Adolescents. J Child Adolesc Psychopharmacol. 2003;13:463–470. - PubMed

Publication types